Molecular biology tools company Zymo Research said on Tuesday that it plans to introduce its ready-to-go processing solution to streamline viral DNA/RNA extraction from nasopharyngeal swabs, oropharyngeal swabs, saliva, sputum, plasma and serum, in partnership with Tecan.
The DreamPrep NAP workstation, which features Zymo Research's Quick-DNA/RNA Viral MagBead Kit, provides pre-loaded scripts and optimized for viral RNA extraction, which are currently being validated for COVID-19 assays by high complexity testing labs.
Zymo's DreamPrep NAP workstation workflows require time-consuming scripting, configuration and optimization for the nucleic acid extraction to function properly, which can dramatically decrease lab scalability in this critical time.
In addition, the preprogrammed, preconfigured, load-and-go system is optimized for high-throughput viral RNA extraction. The workstation features a user-friendly interface and guided setup to streamline implementation, concluded the partnership.
Exact Therapeutics names new CEO
Octapharma USA Extends Funding for COVID-19 Study
ELITechGroup unveils the FreezePoint Freezing Point Osmometer to measure viscous and tissue specimen
Eisai launches new insomnia drug Dayvigo (Lemborexant) CIV in US
Roche's Tecentriq in combination with Avastin gains FDA approval for most common liver cancer